Chemoradiation in Locally Advanced Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to fluorouracil
Related studies linked through entity extraction aliases.
GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE3
Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2